SUBSCRIBE
SUBSCRIBE
News   FDA

OBS Medical Announces FDA Clearance of New Patient Safety Technology

October 1, 2007 | 
1 min read
INDIANAPOLIS--(BUSINESS WIRE)--OBS Medical announced today that the Food and Drug Administration has granted 510(k) clearance for the company to market its next generation patient deterioration early warning system (VisensiaTM) in the United States.
FDA Approvals
MORE ON THIS TOPIC
Email envelope with warning sign on white background
Manufacturing
FDA warning letter accuses Bausch & Lomb of lacking commitment to remediation
September 16, 2026
 · 
2 min read
 · 
Nick Paul Taylor
FDA
FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival
September 16, 2026
 · 
1 min read
 · 
Jef Akst
Creative concept of leadership and innovation with a glowing blue light bulb leading paper planes. Symbol of advanced technology, AI-driven strategy, and visionary direction in a digital future.
Regulatory
FDA opens Operation TrialBlazer for applications, hoping to reshore early trials
September 15, 2026
 · 
1 min read
 · 
Heather McKenzie
People group with speech bubbles. Banner concept of business, internet discuss, news, social networks, chat, dialogue.
Regulatory
Rare disease reform, CMC risk, reshoring US trials top of mind ahead of PDUFA VIII meeting
September 15, 2026
 · 
6 min read
 · 
Heather McKenzie